. 2022 Aug 12;113(10):3510–3517. doi: 10.1111/cas.15496
© 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
FIGURE 2.
ROC curve analysis of the selected miRNAs in the validation set.